Moxifloxacin — Drug Intelligence | 16 EU Trials

Filter these 16 trials by condition, phase, country and more.

Open in Search →

16 Registered trials

10 Recruiting

2 Completed trials

13 Sponsors

18 Countries

Phase III

Phase II

Phase IV

Phase III: 4 Phase II/III: 1 Phase II: 2 Phase IV: 8 Phase I (Other): 1

Oversight events:

1 serious breach 1 temporary halt 1 unexpected event across 2 trials

View oversight register →

Indications tested

Abdominal infection 1 Medical device site joint infection 1 Urinary tract infection 1 Infection 1 Endocarditis enterococcal 1 Sepsis 1 Bacterial infection 1 Mycobacterium abscessus infection 1

Sponsors using this IMP

Turku University Hospital 3 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 2 Achieve Life Sciences Inc. 1 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire De Nantes 1 Hvidovre Hospital 1 Institut Pasteur 1 Pfizer Inc. 1 Rigshospitalet 1 The University Of Queensland 1 Universitair Medisch Centrum Utrecht 1 University Medical Center Utrecht 1

All trials

16 total

Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis Pending

2023-506213-21-00 Phase IV 1 country Turku University Hospital
Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR) Pending

2024-512763-32-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Optimizing the antibiotic treatment of uncomplicated acute appendicitis - APPAC II Pending

2024-518984-36-00 Phase IV 1 country Turku University Hospital
Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC Pending

2024-519392-26-00 Phase IV 1 country Turku University Hospital
Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting

2025-524484-20-00 Phase IV 1 country UZ Leuven
A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradeni… Recruiting

2023-505818-16-00 Phase III 1 country Institut Pasteur
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting

2023-507617-96-01 Phase IV 1 country Rigshospitalet
Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute Recruiting

2022-502974-18-00 Phase II/III 1 country Centre Hospitalier Universitaire De Nice
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting

2022-501575-12-00 Phase II 4 countries Pfizer Inc.
Finding the best treatment for lung disease from infection with Mycobacterium abscessus Recruiting

2023-506575-99-00 Phase II 1 country The University Of Queensland
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended

2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht
A Four Way Crossover Thorough QT/QTc Study to Evaluate the Electrocardiographic Effects of Therapeutic and Supratherapeutic Doses of Cytisin… Ended

2022-500954-40-00 Phase I (Other) 1 country Achieve Life Sciences Inc.

Showing 1–16 of 16 trials

← All drugs A–Z